SONN Insider Trading Activity and SEC Form 4 Filings
SONN insider trading summary
No open-market insider purchases or sales of Sonnet BioTherapeutics Holdings, Inc. (SONN) have been reported on SEC Form 4 in the past 12 months.
Latest SONN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 27, 2023 | Pankaj Mohan | Chairman, President and CEO | Buy | $0 (34,375 @ $0.00) |
| Oct 27, 2023 | Raghu Rao | Director | Buy | $0 (15,625 @ $0.00) |
| Jun 14, 2023 | Susan Dexter | Chief Technical Officer | Buy | $7K (10,000 @ $0.70) |
| May 30, 2023 | Albert D. Dyrness | Director | Buy | $11K (23,255 @ $0.47) |
| May 17, 2023 | Nailesh Bhatt | Director | Buy | $6K (25,000 @ $0.23) |
| May 15, 2023 | Pankaj Mohan | Chairman, President and CEO | Buy | $83K (371,600 @ $0.22) |
| Mar 15, 2023 | Pankaj Mohan | Chairman, President and CEO | Buy | $35K (60,000 @ $0.58) |
| Jun 9, 2021 | Pankaj Mohan | Chairman, President and CEO | Buy | $6K (4,000 @ $1.54) |
| Jun 9, 2021 | Pankaj Mohan | Chairman, President and CEO | Buy | $43K (28,000 @ $1.55) |
| Jun 9, 2021 | Richard T Kenney | Chief Medical Officer | Buy | $23K (15,000 @ $1.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.